NEW YORK – Exagen today announced it has closed a financing round that raised $22.6 million.
The funds will go toward ongoing commercialization of the Vista, California-based firm's autoimmune tests and therapeutics promotion business, Exagen said.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.